WASHINGTON, June 10 /PRNewswire-FirstCall/ -- Abbott announced today the presentation of results from two new studies that met the predefined endpoints designed to assess the accuracy, safety and efficacy of the FreeStyle Navigator(TM) Continuous Glucose Monitoring System for children and adults. Both studies will be presented during poster sessions beginning Saturday, June 10th, at the 66th annual Scientific Sessions of the American Diabetes Association.
